IMDZ Insider Trading Activity and SEC Form 4 Filings
IMDZ insider trading summary
No open-market insider purchases or sales of Immune Design Corp. (IMDZ) have been reported on SEC Form 4 in the past 12 months.
Latest IMDZ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 7, 2019 | Carlos V Paya | President and CEO | Sell | $21K (13,014 @ $1.58) |
| Jan 7, 2019 | Stephen R Brady | EVP, Strategy & Finance | Sell | $9K (5,516 @ $1.58) |
| Jan 7, 2019 | Sergey Yurasov | Sr. VP, Clinic. Devel. & CMO | Sell | $6K (3,522 @ $1.57) |
| Jan 7, 2019 | Meulen Jan Henrik ter | Chief Scientific Officer | Sell | $5K (3,414 @ $1.59) |
| Dec 4, 2018 | Biotechnology Value Fund L P | Insider | Sell | $789K (430,035 @ $1.83) |
| Dec 4, 2018 | Biotechnology Value Fund II LP | Insider | Sell | $789K (430,035 @ $1.83) |
| Dec 4, 2018 | Bvf Inc/Il | 10% Owner | Sell | $165K (89,948 @ $1.83) |
| Dec 4, 2018 | BVF Partners OS Ltd. | Insider | Sell | $789K (430,035 @ $1.83) |
| Dec 4, 2018 | Bvf Partners L P/Il | 10% Owner | Sell | $789K (430,035 @ $1.83) |
| Dec 4, 2018 | Bvf Inc/Il | 10% Owner | Sell | $789K (430,035 @ $1.83) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.